Home › Concussion › NCT07282691

Validation of Clinical Outcome Measures Specific to mTBI-Related Oculomotor Disorders

Who can join

Ages 18 to 35 · All sexes · Healthy volunteers welcome

Inclusion Criteria:

* Diagnosis of mTBI within previous 1 to 6 months
* Distance visual acuity better than or equal to 20/25 in each eye
* Score \>21 on Convergence Insufficiency Symptom Survey

Exclusion Criteria:

* Diagnosis of moderate or severe TBI; \> 30-min loss of consciousness
* Not wearing required refractive error)
* Disease(s) known to affect oculomotor system (multiple sclerosis, Graves orbitopathy, myasthenia gravis, diabetes mellitus, or Parkinson disease)-Manifest strabismus or intraocular injury (evaluated at vision examination)
* Cognitive delays that may impact testing

About the study

The specific aim of this project is to validate clinical tests to be used as outcome measures in studies of mTBI-related vision problems.

Sponsor: Salus University · Participants: 150 · Started: Apr 1, 2025

Contact the study team

• Katie Holmbeck, BS · Phone: 2157801429
• Mitchell Scheiman, OD, PhD · Phone: 2157801427

Official record on ClinicalTrials.gov — NCT07282691

Locations in the U.S.

Conditions

• Concussion
• Eye Movement Disorders

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.